Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC124

N-(5-hýdroxý-2,4-dítert-bútýl-fenýl)-4-oxó-1H-kínólín-3-karboxamíð eða lyfjafræðilega nothæft salt þar af

  • Status:
    Veitt
  • Application date:
    6.7.2015
  • Application published:
    15.8.2015
  • Grant published:
    15.11.2016
  • Max expiry date:
    24.1.2028
  • Next due date:
    30.6.2026
  • Medicine name:
    Kalydeco
  • Medicine for children:
    Yes

Timeline

Today
6.7.2015Application
15.8.2015Publication
15.11.2016Registration
23.6.2026Expires

Marketing license

  • IS authorization number:
    EU/1/12/782/001-002
  • Date:
    22.8.2012
  • Foreign authorization number:
    EU/1/12/782/001-002
  • Date:
    23.7.2012

Owner

  • Name:
    Vertex Pharmaceuticals Incorporated
  • Address:
    50 Northern Avenue, Boston US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 10.6.2025

Expires: 23.6.2026

Payer: Árnason Faktor ehf.

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 12.10.2025

Upload documents